Rekrutierung

Eingeschlossene Patienten: 19.523 (Stand 02. Juni 2020)
Amgevita® (Adalimumab)	74
Benepali® (Etanercept)	692
Cimzia® (Certolizumab)	919
Enbrel® (Etanercept)	2863
Erelzi® (Etanercept)	255
Flixabi® (Infliximab)	6
Hulio® (Adalimumab)	32
Humira® (Adalimumab)	2904
Hyrimoz® (Adalimumab)	57
Idacio® (Adalimumab)	2
Imraldi® (Adalimumab)	79
Inflectra™ (Infliximab)	16
Kevzara® (Sarilumab)	126
Kineret® (Anakinra)	89
MabThera® (Rituximab)	1459
Olumiant® (Baricitinib)	390
Orencia® (Abatacept)	828
Remicade® (Infliximab)	762
Remsima® (Infliximab)	10
Rinvoq® (Upadacitinib)	21
Rixathon® (Rituximab)	11
RoActemra® (Tocilizumab)	1330
Simponi® (Golimumab)	445
Xeljanz® (Tofacitinib)	294
Zessly® (Infliximab)	2
Kontrollen	5857